Navigation Links
Diabetes drug may prevent or delay development of polycystic ovary syndrome
Date:6/29/2011

Chevy Chase, MD A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) found that early, prolonged treatment with the diabetes drug metformin may prevent or delay the development of polycystic ovary syndrome (PCOS) in adolescence.

PCOS affects 7 to 10 percent of women of childbearing age and is the most common cause of infertility, affecting an estimated 5 to 6 million women in the United States, according to The Hormone Foundation.

"PCOS often presents in adolescence, with irregular menstrual cycles, acne, or too much body hair," said the study's senior author, Lourdes Ibez, MD, PhD, professor of pediatrics at the University of Barcelona in Spain and lead author of the study. "But we believe the critical years for PCOS development may be during childhood and puberty when excessive amounts of fat are stored. That excessive weight gain overexposes the ovaries to insulin, causing them to stop ovulating and start releasing male hormones, resulting in PCOS."

In this study of 38 girls with low birth-weight and early puberty, researchers compared the efficacy of early versus late metformin treatment to prevent adolescent PCOS. A group of 19 8-year-old girls were treated with daily doses of metformin for four years. A second group of 19 girls waited five years before they began receiving daily doses of metformin at age 13 and then continued treatment for only one year. They found that early metformin therapy prevented or delayed the development of hirsutism, androgen excess and PCOS more effectively than late metformin treatment.

"Metformin, when given across the potentially critical window of puberty, may have the capacity to reprogram metabolism toward less abdominal and liver fat," Ibez concluded. "In the years ahead, the focus of attention should shift from late treatment of PCOS and its complications, toward the early and large-scale prevention of PCOS,
'/>"/>

Contact: Aaron Lohr
alohr@endo-society.org
240-482-1380
The Endocrine Society
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Preventing Type 2 Diabetes Saves Money: Study
2. Trials of Type 1 Diabetes Vaccines Bring Mixed Results
3. Chemical produced in pancreas prevented and reversed diabetes in mice
4. Working Night Shifts May Raise Diabetes Risk for Women
5. Diabetes on Upswing Worldwide
6. Genetic study shows that low body fat may not lower risk for heart disease and diabetes
7. Massachusetts General Hospital, Iacocca Foundation announce promising results of Phase I diabetes trial
8. After Diabetes Diagnosis, Concentrate on Dietary Changes, Study Says
9. 350 million adults have diabetes: Study reveals the scale of global epidemic
10. Life expectancy for those with Type 1 diabetes improving, Pitt study says
11. Cautionary tale for people with diabetes: Dog consumed part of a sleeping patients toe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... ... 2015 , ... The Erie County Bar Association Institute of ... Association welcomed speaker C. Daniel McGillicuddy Esq. of William Mattar Law Offices. ... these types of cases. , Each year, New York State residents are hospitalized ...
(Date:7/3/2015)... ... July 03, 2015 , ... " Selfie on a Stick ... the latest and coolest technology products available to consumers. Amanda Forstrom, a technology expert ... selfie sticks are great for documenting memories. , Almost every smartphone has an incredibly ...
(Date:7/2/2015)... ... ... pleased to announce the opening of its newest location in Dallas, Texas. The opening is ... chain was listed as #22 on the Inc. 500 list of fastest growing companies in ... located at:, 3701 W. Northwest Highway, STE 430, Dallas, TX 75220 , “We are excited ...
(Date:7/2/2015)... ... , ... Many Fourth of July celebrations will include fireworks this summer, so ... sharing some tips to promote the proper use of fireworks. , According to the ... daily with fireworks-related injuries in the month surrounding the Fourth of July. Amica is ...
(Date:7/2/2015)... CITY, GA (PRWEB) , ... July 02, 2015 ... ... field sporting the newest shades of the SIGVARIS PERFORMANCE SOCKS. Since the socks ... fitness experts and athletic trainers. Their significant popularity has inspired four new, fun ...
Breaking Medicine News(10 mins):Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:sweetFrog Opens 18th Location in the Lone Star State 2Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2
... supply for the ... healthcare industry, OTTAWA, Oct. ... radiopharmaceuticals, signed a 17-year,contract for the supply of cobalt-60 with Rosenergoatom, ... the,2005 agreement by providing for an increased supply of cobalt-60 to ...
... New Non-Steroidal Skin Treatment to Treat All ... with Steroids, BARRINGTON, Ill., Oct. 19 Steroids have ... abuse. There must be reasons why,people use steroid products on ... largest organ of the human body, and it needs to ...
... 19 VioQuest,Pharmaceuticals (OTC Bulletin Board: VQPH), ... developing and,commercializing targeted cancer therapeutics, announced today ... presentations pertaining to VQD-002 (TCN-PM),and Lenocta(TM) (SSG) ... Conference sponsored by the American Association for ...
... per month, experts say , FRIDAY, Oct. 19 (HealthDay News) ... severe kidney disease could help improve patients, quality of life, ... giving patients an anti-anemia drug as infrequently as once a ... the Renal Research Institute in New York, and colleagues. , ...
... Earnings Per Share Exceeds Guidance -, EXTON, Pa., Oct. ... the results for its first quarter of fiscal,year 2008. ... which include net sales,and royalty income, were $17.6 million in ... $16.3 million in the prior year first quarter. Net ...
... Israel, October 19 Healthcare,Technologies Ltd. (NASDAQ: HCTL ... shareholders, previously scheduled for September 30,2007, will be held ... offices of,Yigal Arnon & Co., 1 Azrieli Center, Round ... shareholders will be asked to approve the previously,announced Asset ...
Cached Medicine News:Health News:MDS Nordion signs 17-year contract with Rosenergoatom 2Health News:Steroids Are Abused for Skin, Not Just Muscles 2Health News:VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting 2Health News:VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting 3Health News:VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting 4Health News:VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting 5Health News:Simpler Anemia Treatment May Help Kidney Patients 2Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 2Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 3Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 4Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 5Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 6Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 7Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 8Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 9Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 10Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 11Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 12Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 13Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 14Health News:Healthcare Technologies Announces New Date for the Shareholders Meeting to Approve the Nexgen Biofuels Transaction 2Health News:Healthcare Technologies Announces New Date for the Shareholders Meeting to Approve the Nexgen Biofuels Transaction 3
(Date:7/3/2015)... Redwood Pharma AB has entered ... operating in both the US and China ... supramolecular hydrogel technology in its lead chronic Dry ... The Broda technology offers many unique competitive benefits. At ... and with low concentrations of polymer the system can ...
(Date:7/2/2015)... TX and VANCOUVER , July ... "Company") (TSX-V: EPI) announced today that its common shares have ... Market ("NASDAQ") under the symbol "EPIX". ESSA will ... will retain its listing on the TSX Venture Exchange under ... listing of the common shares on the NASDAQ, each of ...
(Date:7/2/2015)...  Before you head outdoors with your family to enjoy ... and healthy. Take steps to protect yourself from the sun, ... Protect Your Skin From the Sun Exposure ... risk of skin cancer. To protect your skin from UV ... during midday hours. Wear a hat with a wide brim ...
Breaking Medicine Technology:Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4First Aid Summer Survival Tips from Nyack Hospital 2First Aid Summer Survival Tips from Nyack Hospital 3
... Sept. 17 Optovue, the company that launched the ... announced that it has received 510(k) clearance on its ... "This affirms that our protocols and management of ... level that FDA regulatory guidelines require," stated Mike Sinai, ...
... Medical, Inc., a leading innovator of noninvasive physiological monitoring ... the 1000USB-C USB adapter. Designed for OEM system developers, ... to conveniently transfer secure data in accordance with Continua ... a line of USB adapters released by Nonin this ...
Cached Medicine Technology:Optovue Receives FDA Clearance on OCT Normative Database 2Nonin Medical Announces Continua™ Certified USB Data Transfer Device for Its Handheld Oximeter Line 2
Intermittent catheter...
Enhanced drug and formulary reference with integrated ID treatment guide and tools. Increase patient safety and satisfaction with our premium drug reference....
... Flexible Band is a flexible partial ... alternative for surgeons who desire posterior ... Tailor® Annuloplasty Ring, which is designed ... rings, but like the option of ...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,407-0) or contact custom...
Medicine Products: